Drugs / Polyglucosamine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03557424 | Apr 2017 → Apr 2018 | — | Heilpflanzenwohl AG | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Polyglucosamine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03557424 ↗ |
| Modality | Other / unclassified | “approved medical device containing a combination of chitosan (a polyglucosamine ) and glucomannan” NCT03557424 ↗ |
| Route | Oral | “The solution is taken orally.” NCT03557424 ↗ |